Prophylactic Ketorolac Post Epiretinal Membrane Surgery

A Placebo-controlled, Randomized, Clinical Trial of Prophylactic Ketorolac 0.5% in Patients Undergoing Pars Plana Vitrectomy and Phacovitrectomy Epiretinal Membrane Peel Surgery: Assessing Macular Volume With Spectral-domain OCT

Evaluate the efficacy of ketorolac 0.5%, a topical non-steroidal anti-inflammatory drug (NSAID), to prevent macular edema after epiretinal membrane surgery. Patients undergoing epiretinal membrane surgery have increased risk of macular swelling which can adversely affect vision. Since post-intraocular surgery inflammation is a contributing factor to macular swelling and loss of vision, NSAID drops may be able to prevent or minimize the deleterious effects of macular swelling after epiretinal membrane surgery.

Inclusion Criteria:

• idiopathic epiretinal membrane diagnosis requiring membrane peel surgery

Exclusion Criteria:

• proliferative diabetic retinopathy
• sickle cell retinopathy
• radiation retinopathy
• choroidal folds
• hypersensitivity or allergy to NSAIDs
• wet macular degeneration
• branch retinal vein occlusion (BRVO)
• central retinal vein occlusion (CRVO)
• complicated membrane peel surgery